On November 3, Remedy Entertainment announced its Q3 2026 (July–September) revenue of €39.6 million (approx. 59.5 billion won), up 226.0% compared to €12.2 million in the same period last year. During the same period, operating results also turned profitable, shifting from an operating loss of €16.4 million in Q3 last year to an operating profit of €600,000 (approx. 900 million won) this quarter.
| 📒 | - Q3 revenue of €39.6 million, up 226% YoY - Pre-orders and initial 7-day sales of 'Control Resonant' reflected - Operating profit turns positive at €600,000... Cumulative operating results remain in deficit |
The primary driver behind the revenue surge was 'Control Resonant', which launched globally on September 24. Remedy stated that pre-orders and sales from the first 7 days following release were fully reflected in the Q3 financial results. On October 15, after the quarter's close, global cumulative sales surpassed 1 million units, marking the fastest sales pace of any title in Remedy's history.
'Control Resonant' features the previous protagonist Jesse Faden's brother, Dylan, as the main lead, while expanding the setting from the Federal Bureau of Control's Oldest House to Manhattan, New York. Moving away from the gunplay-focused action of its predecessor, the game reinvented itself as an action RPG that combines shapeshifting melee weapons with aerial levitation traversal.
Game sales and royalty revenues in Q3 reached €35.3 million, accounting for 89% of total quarterly revenue. This represents a nearly sixfold increase compared to €6.0 million in the same period last year. This figure includes not only the new title, but also sales of the previous game 'Control' and 'FBC: Firebreak', alongside royalties from the 'Alan Wake' series. Development fee revenue of €4.3 million stemmed from final development fees related to the 'Max Payne 1&2 Remake' and the new title. Remedy added that the combined effect of the new release and promotional efforts for previous titles propelled Q3 sales of the original 'Control' past both the same period last year and the preceding two quarters.
This new title marks Remedy's first major self-published game. Under the structure, Remedy shares a portion of the game's revenue with Annapurna Pictures—with whom it entered a co-financing partnership in 2024—and directly bears platform fees. Consequently, Q3 materials and services expenses rose to €20.0 million, an increase of €17.0 million year-over-year, while other operating expenses grew to €8.0 million due to concentrated marketing spend. Amortization of capitalized development costs also began in earnest upon release.
The large operating loss in Q3 last year was heavily impacted by a non-cash impairment charge of €14.9 million related to 'FBC: Firebreak'. Despite turning an operating profit this quarter, net profit/loss for Q3 after financial items and taxes registered a net loss of €100,000, and cumulative operating results for January to September remained in deficit at a loss of €2.3 million. Cumulative revenue from January to September rose 48.2% year-over-year to €62.9 million. Remedy maintained its previous performance guidance that full-year 2026 revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization) will grow compared to the prior year.
